Context: Docosahexaenoic acid (DHA) is an important fatty acid required for neurological development but its importance during early fetal neurological organogenesis is unknown.
T he long-chain polyunsaturated fatty acids (LC PUFA), docosahexaenoic acid (DHA) and arachidonic acid (AA), are important in neurological development because these lipids are key membrane components of nervous tissues (1, 2) . The fetal-placental circulation is established at approximately 9 -13 weeks of gestation, after which the growing fetus preferentially acquires DHA and AA from maternal plasma via placental transport (3, 4) . In contrast, the essential dietary fatty acids linoleic acid (LA) and ␣-linolenic acid (ALA), which are the precursors of LC PUFA, are at best minimally transferred to the fetus from maternal plasma (3, 5) . We have previously shown that maternal erythrocyte DHA concentrations (an indicator of the previous 3-mo change in concentration) increased 17% by the end of the first trimester and continued to significantly increase throughout pregnancy to 26% above postpartum (nonpregnant) concentrations by the third trimester (6) . AA concentrations did not change but the concentration of nervonic acid important in myelination, increased by 5 and 22% by the end of the first and third trimester, respectively (6) . Thus, plasma concentrations of fatty acids essential for brain development are increased by the end of the first trimester and are available for placental transport to the fetus.
The sources of LC PUFA for this increase in plasma concentration or "mobilization" in pregnant women have not been fully identified and could include ingestion in maternal diet, maternal synthesis from shorter-chain precursors or release from maternal membrane stores and adipose tissue. Our previous study suggested that ALA, but not LA, is mobilized for LC PUFA synthesis in pregnancy (6) . Humans possess the necessary enzymes to metabolize these two precursor fatty acids to LC PUFA (Supplemental Figure 1 ). Healthy, nonpregnant individuals can convert LA to AA by desaturation (␦-6 desaturase/ FADS2), elongation (ELOVL5), and further desaturation (␦-5 desaturase/FADS1) in the liver (7) . These same enzymes, in parallel, also convert ALA to eicosapentaenoic acid (EPA) and ultimately DHA but these conversions, particularly to DHA, are limited. Interestingly, this pathway is more efficient in women than in men, suggesting sex-specific roles for this pathway (8) . The dominance of the omega-6 LC PUFA pathway can be explained by the competition of LA and ALA for the same ␦-6 desaturase enzyme, given that dietary LA intake is 8-fold higher than that of ALA (9) .
The critical requirement of DHA for fetal brain development, and the poor efficiency of its synthesis in humans, is therefore a metabolic problem to be overcome in pregnancy. Furthermore, given that the first primitive brain cells are formed by day 15 of gestation, neural tube-closure occurs by 28 days' gestation and the head of the embryo grows fastest in the early gestational weeks, we hypothesized that changes in maternal plasma LC PUFA concentration prior to 13 weeks' gestation are vitally important. Unfortunately, the direct assessment of maternal fatty acid changes from prepregnancy to the first weeks of gestation is difficult in a free living population, and there are no data on these earliest changes. Our aim, therefore, was to assess plasma fatty acid changes in very early pregnancy in a population of women undergoing natural cycle-frozen embryo transfer as a means of achieving accurately timed periconceptual sampling.
Materials and Methods

Study design, setting, and participants
This prospective, observational study was conducted at Glasgow Royal Infirmary and was approved by the Local Research Ethics Committee (07/S0704/49). Women undergoing frozen embryo transfer (FET) treatment for infertility were recruited from the Assisted Conception Unit between October 2007 and April 2010. Women were eligible for the study if they had a regular menstrual cycle. Patients who had ovulation stimulation or induction were excluded. No progesterone supplementation or other hormonal supplements were given. All women were recommended to take 400 g per day of folic acid in line with World Health Organization guidelines. Women were informed of the study when notifying the clinic nurse of their last menstrual period (LMP) date with a view to booking FET treatment. At day 10 after LMP (pre-luteinizing hormone [LH] surge), the women attended the Assisted Conception Unit to commence daily hormonal sampling to detect the LH surge and time embryo replacement. At this point women provided written informed consent and a basal blood sample. Embryo transfer was performed on day 3 post-LH surge. Information on patient demographics and fertility history was collected from patient notes. Patient height and weight data were collected at the pre-LH surge visit. Body mass index (BMI) was calculated as weight in kg divided by height in meters squared. Scottish Index of Multiple Deprivation (SIMD) quintile (10) was derived from patient postcode.
Blood sampling
Fasting blood samples were collected approximately day 10 after LMP (pre-LH surge) and on days 18, 29, and 45 post-LH surge. Plasma was collected by low-speed centrifugation and frozen at Ϫ80°C within 2 hours. At day 18 post-LH surge the women who were not successful in getting pregnant withdrew from the study and therefore did not provide any blood samples at days 29 and 45 post-LH surge.
Plasma analysis
Fatty acids were extracted from plasma and analyzed as described in detail in the Supplemental Methods.
Statistical analyses
Data were tested for normal distribution using a Ryan Joiner test and log or square root transformed when necessary. Values for continuous biochemical variables are given as mean Ϯ SD or number (%) for categorical variables. The rate of change of fatty acids between time points was calculated as the difference between the fatty acid concentration at the second time point and at the first time point divided by the difference in time (days) between the two time points. The results are expressed as nmol/mL plasma per day. Incremental area under the concentration (pre-LH surge to 45 d post-LH surge) ϫ time curve (iAUC) were calculated using the trapezium method with correction for pre-LH surge parameter level (11) . The results are expressed as nmol/mL ϫ day. Differences in concentrations of fatty acids over time were assessed by one-way ANOVA for repeated measures, with between-group comparison using posthoc Tukey-Kramer HSD. Simultaneous difference testing between twin and singleton pregnancies across time points was carried out using a univariate split-plot approach repeated measures analysis with post-hoc ANOVA for specific time/twin singleton pregnancy differences. Associations between variables were examined using univariate regression analysis. Prediction of successful pregnancy outcome at day 45 post-LH surge using 18-day post-LH surge data was assessed by univariate and multivariable logistic regression. Stepwise logistic regression was used to select variables to include in multivariable models with the significant levels to enter and stay in model set at P Ͻ .05. Results are reported as odds ratio (OR) [95% confidence interval], associated P-value, and the C-statistic for the area under the curve (AUC). ORs represent an increase of 1 U unless otherwise stated for continuous variables. Statistical analyses were performed using the JMP statistical analysis program (Version 9.02, SAS Institute) or SAS (Version 9.2, SAS Institute) and statistical significance was set at ␣ Յ 0.05 for all analyses.
Results
Study population
A total of 196 FET cycles were started in the study, of which 161 were completed, from which there were 38 pregnancies: two were excluded as being a repeat attempt at FET treatment within the study and nine were excluded as they did not have complete data for all visits; therefore, 27 pregnant women were included. Of the 161 FET cycles completed, there were 123 failed pregnancies, of which 35 had full fatty-acid data (Supplemental Figure 2) . Table 1 shows the demographic characteristics of the 27 pregnant women and 35 women not successful in getting pregnant and there were no significant differences between the two groups of women, except that use of intra-cytoplasmic sperm injection was significantly more prevalent in the women who became pregnant.
Plasma fatty acid concentrations over the first 45 days post-LH surge
The baseline prepregnancy sample was taken at the time of sampling to identify the LH surge prior to the women receiving FET. The mean time of this sample was 3 days prior to the LH-surge with a SD of 3 and a range of Ϫ12 to ϩ1 day relative to the LH surge. Plasma fatty-acid concentrations over time are shown in Table 2 . Palmitic, stearic, and oleic acid concentrations were significantly reduced by 12-15% by day 18 post-LH surge but their concentrations returned back to pre-LH surge levels by day 45 post-LH surge. Lignoceric acid concentration was significantly decreased by 10% by day 29 and was sustained at day 45 post-LH surge. There was no change in AA but there was a trend for a 10% reduction in LA concentration by day 18 post-LH surge, which was maintained at days 29 and 45 post-LH surge. ␥-linolenic acid concentration was significantly decreased by 29% by day 18 post-LH surge and remained at that concentration at day 29 post-LH surge. Dihomo-␥-linolenic acid, adrenic acid, and omega-6 docosapentaenoic acid (DPA) concentrations were significantly increased by 19, 36, and 71%, respectively. There were no changes in plasma ALA and omega-3 DPA with time, but EPA concentration decreased by 29% by day 45 post-LH surge, although the post-hoc analysis did not result in significance. DHA concentration was significantly increased by 31% by day 45 post-LH surge.
The ratio of dihomo-ϒ-linolenic acid to LA is indicative of ␦-6 desaturase activity. The ratio of plasma dihomo-ϒ-linolenic acid to LA concentration (mean Ϯ SD) was 0.054 (0.012), 0.058 (0.011), 0.060 (0.0113), and 0.070 (0.016) for pre-LH surge and days 18, 29, and 45 post-LH surge, respectively. The increase in ␦-6 desaturase was significant by day 45 post-LH surge (P ϭ .0002). In the women who were not successful in getting pregnant, there were no significant changes in plasma fatty acids from pre-LH surge to day 18 post-LH surge.
Rate of change of plasma fatty acid concentrations and iAUC during the first 45 days post-LH surge
The only plasma fatty acid with a continual increasing rate of change in concentration ( Figure 1A ) and a positive iAUC ( Figure 1B ) was DHA. The greatest rate of change in DHA was from day 18 -29 post-LH surge, when the rate of change of DHA concentration correlated significantly with an index of ␦-6 desaturase activity; R 2 adjusted ϭ 41%, P ϭ .0002 (Supplemental Figure 3) . Outside this time window, no such correlations were present (pre-LH surge to day 18: R 2 adjusted ϭ Ϫ4%, P ϭ .29; day 29 to 45 post-LH surge: R 2 adjusted ϭ 0.1%, P ϭ .32). The other omega-3 PUFA all had stable or decelerated rates of change in plasma concentration. ALA had a negative iAUC ( Figure 1B ), which could result from increased removal from the plasma compartment by being converted to EPA, DPA, and DHA. There was an initial decrease in the rate of change of plasma AA concentrations from pre-LH surge to day 18 post-LH surge, which then switched to increased rates of change of plasma AA be- press.endocrine.org/journal/jcemtween days 18 and 45 post-LH surge ( Figure 1A ). However, overall there was no net change in AA concentration: the iAUC was zero ( Figure 1B ). Other major plasma fatty acids also initially showed declining rates of increasing plasma concentration from pre-LH surge to day 18 post-LH surge, which then switched to higher rates of increasing plasma concentration between days 18 and 45 post-LH surge ( Figure 2A) ; however, their iAUCs were all negative ( Figure 2B ), suggesting a loss of these fatty acids from the plasma compartment over 45 days. Of note is the rapid decline in plasma concentration and a corresponding large negative iAUC of LA, as a decrease in LA concentration may allow ␦-6 desaturase to favor DHA synthesis from ALA (Supplemental Figure 1) .
Plasma DHA and omega-6 DPA concentrations over the first 45 days of gestation in twin pregnancies Increases in both DHA and omega-6 DPA concentrations were approximately 2-fold higher in twin compared with singleton pregnancies (Table 3) . By day 45 post-LH surge DHA plasma concentration was significantly raised both in singleton and twin pregnancies and the increase from pre-LH surge levels was greater in twin (74 nmol/mL) than singleton (36 nmol/mL) pregnancies. This 2-fold higher change in DHA concentration was also observed earlier at day 29 post-LH surge: twin (161-131 ϭ 30 nmol/mL) vs singleton (163-149 ϭ 14 nmol/mL). The iAUC for DHA in twin pregnancies (1341 Ϯ 936 nmol/mL over 45 d) was significantly higher (P ϭ .013) than singleton pregnancies (384 Ϯ 781 nmol/mL over 45 d). At day 29 post-LH surge, omega-6 DPA change in concentration from pre-LH surge was 3-fold higher in twin (2.4 nmol/mL) vs singleton (0.8 nmol/mL) pregnancy and 2-fold higher at day 45 post-LH surge (7.4 nmol/mL) vs (3.1 nmol/mL), respectively. The iAUC for omega-6 DPA tended also to be higher in twin pregnancies (96 Ϯ 49 nmol/mL over 45 d) than in singleton pregnancies (23 Ϯ 95 nmol/mL over 45 d) but this did not reach significance (P ϭ .060). In a multivariate mixed model, plasma DHA levels were higher as gestation progressed (P Ͻ .0001) but did not differ between twin and singleton pregnancy overall (P ϭ .97). A borderline significant interaction between days of gestation and twin pregnancy (P ϭ .06) suggests that DHA plasma concentration increases are higher in twins compared with singleton pregnancies in response to pregnancy (R 2 adjusted, 83%). In a multivariate mixed model, plasma omega-6 DPA levels were associated with day of gestation (P Ͻ .0001) and were higher overall in twin pregnancy (P ϭ .04). However, the nonsignificant interaction between days of gestation and twin pregnancy (R 2 adjusted, 64%; P ϭ .10) provides less evidence that plasma omega-6 DPA concentration is increased to a greater extent in twin pregnancy.
LA and pregnancy outcome
There was a significant 10% reduction in plasma LA concentration between pre-LH surge and day-18 post-LH surge in pregnant women (P ϭ .017) but not in women who were not successful in getting pregnant (P ϭ .63). Multivariable stepwise logistic regression analysis considering all day-18 post-LH surge variables (including erythrocyte fatty acid composition and insulin data not shown here) measured in women who became pregnant and those women who did not showed that at high insulin levels, low LA levels and high erythrocyte saturated fatty-acid levels were associated with successful pregnancy at day 45 post-LH surge (C-statistic ϭ 0.78) ( Table 4) .
Discussion
This study observed, for the first time, that uniquely among the fatty acids measured, DHA showed a net increase in concentration during the first 45 days of preg- Abbreviations: LHS, luteinizing hormone surge; MUFA, monounsaturated fatty acids; NP, not successful in becoming pregnant; Preg, successful pregnancy; PUFA, polyunsaturated fatty acids; SAFA, saturated fatty acids.
Means (SD) are shown.
Differences between concentrations were tested using one-way ANOVA for repeated measures, across sampling from pre-LH surge (prepregnancy) to 18, 29, and 45 d post-LH surge and P values are given.
NP women withdrew from the study after blood pregnancy testing at day 18 post-LH surge and therefore 29 and 45 d post-LH surge samples are not available (ns) for these women. press.endocrine.org/journal/jcemnancy with the highest rate of increase being observed after day 18 post-LH surge. This early pressure to increase plasma DHA concentration was further emphasized in twin pregnancies where the increase in concentration was double that in singleton pregnancies. A 14% increase in plasma volume at day 70 of gestation (12) suggests a change in plasma volume of 6% at day 18 post-LH surge and slightly higher (7%) in twin pregnancy (13) . This increase in plasma volume cannot account for the differences in DHA concentrations observed here. The plasma fatty acids measured in this study reflect a complex mixture of fatty acids bound to albumin plus those fatty acids contained within lipoprotein particles, the transport of which is very complex requiring detailed isotope tracer kinetic studies, which are beyond the scope of this study.
The rapid and early increase in maternal plasma DHA concentration is consistent with our hypothesis that this fatty acid is of critical importance early in pregnancy. DHA, a major structural lipid in the brain, interacts with the plasma membrane protein syntaxin-3, which is required for the membrane fusion necessary for neurite outgrowth in developing neurons (14) . Previous data have shown its importance during the latter stages of pregnancy when the brain accrues its tissue mass (15) . Our data shows that DHA is also important during the very early stages of pregnancy when embryological nervous tissue is beginning to form. The timing of the increase in plasma DHA concentration is coincident with the time at which the very first primitive nerve cells seem and, by the time of neural tube closure at around 28 days' gestation, the plasma concentration of DHA has increased significantly by 31% and a steady rate of increasing plasma concentration has been reached.
The early increase in maternal plasma DHA concentration could be achieved either through its release from body stores or via increased synthesis. Diet is unlikely to be substantially changed over such a short period of time, but cannot be discounted. Humans do not store substantial amounts of DHA in adipose tissue, yet there is sufficient DHA content (16) and total adipose tissue mass in pregnant women that its release from adipose tissue could contribute to the increase in plasma concentration observed here. Another likely source is maternal de novo synthesis in the liver. The fractional conversion rates of ALA to DHA in men is only 0.04% (17) with women being higher at 9% (8). Our observations that 1) the initial plasma concentrations of ALA and EPA decrease before rebounding between day 18 and 45, 2) the significant 10% reduction in plasma LA in pregnant women, and 3) the accelerated increase in plasma concentration of DHA between days 18 and 29 post-LH surge was correlated with an index of ␦-6 desaturase activity, are all consistent with increased synthesis of DHA from its precursors. This agrees with observations in pregnant rats where plasma and liver DHA concentration as well as liver FADS2 (␦-6 desaturase) mRNA expression were increased by gestation day 20 (18) . The increase in liver FADS2 mRNA expression was positively correlated with plasma concentrations of pregnancy hormones; estradiol, and progesterone (18) , suggesting that these hormones are responsible for up-regulating DHA synthesis. The ability of women to convert more ALA to DHA has also been attributed to the presence of estrogen (8) and postmenopausal women receiving estrogen therapy have increased conversion (19) . Low levels of LA have previously been shown to be associated with increased DHA levels in mothers in the third trimester and in their newborns (20) , and this low placental transport of maternal LA allowed ␦-6 desaturase activity to be directed more toward converting ALA to DHA (20) . Furthermore, the current study shows that low levels of LA is a predictor of successful pregnancy as indicated by positive fetal heartbeat at day 45 post-LH surge.
The substantial decrease in maternal plasma ␥-linolenic acid and the resultant increases in dihomo-␥-linolenic acid and omega-6 DPA suggest that the synthesis of omega-6 DPA is important because it can be used as a substitute when DHA supply is limited (21) . In the eye, omega-6 DPA is incorporated into rhodopsin-containing membranes when DHA concentration is low, albeit with a resultant reduction in visual acuity (22) and supplementation with DHA in infants may increase visual acuity (23) . In DHA deficiency, omega-6 DPA is used in place of DHA in brain which seems to be a survival mechanism (24 -26) . Our Fatty acids in oocytes are primarily saturated fatty acids, oleic acid, and virtually no omega-3 PUFA (27) . Once an oocyte has been released from the ovary, the oocyte and any resultant embryo needs to rely on its own energy source and oocytes express the relevant lipases to release fatty acids from triglyceride (28) . Interestingly, inhibition of oocyte fatty acid oxidation in vitro reduces blastocyst formation and reduces the number of cells within each blastocyst (29) . Thus, saturated fatty acids are key to successful embryo formation and implantation (30) . Sperm, in contrast, contain predominately DHA (31) , which upon fertilization of the oocyte, delivers at least some of the DHA needed for very early neurological development. After implantation, the embryo must rely on fuels transported directly to the embryo from the mother until the fetal/maternal circulation is established at 9 -11 weeks of gestation. Our data show increased plasma concentrations of palmitic acid and oleic acid between days 18 and 45 post-LH surge, consistent with these fatty acids being used to meet the energy requirements by the embryo. Exactly how the embryo obtains fatty acids from the maternal circulation is yet to be elucidated, but there is evidence for their simple diffusion across lipid vesicles (32) .
The strengths of this study were the prospective study design, with repeated within-individual sampling up to day 45 post-LH surge and the comprehensive analysis of fatty acid profiles measuring absolute concentrations. The main limitation of this study was that women undergoing in vitro fertilization are not a "normal" pregnancy population and it should be noted that over 40% of the women were undergoing assisted conception due to problems with female fertility. However, the women had a natural menstrual cycle, meaning there was no interference of exogenous hormones used in cycle reconstruction on their metabolic adaptation to pregnancy. Frozen rather than fresh embryos were transferred, but this should not affect the maternal metabolic response to implantation of that embryo. The major advantage of the population used was the ability to get accurately timed periconceptual and early pregnancy blood samples that would be extremely difficult to achieve from a free-living population. There was no dietary intake data, no information on morning sickness and due to being unable to collect relevant tissues, no direct measure of ␦-6 desaturase activity and no assessment of embryo/fetal tissue accrual of fatty acids. Inferences on changes in fatty acid metabolism were made using serial steady state plasma fatty acid concentrations. Although we can observe increases and decreases in plasma concentration, it does not fully establish whether these changes in concentration were due to changes in rates of entry into or removal from plasma compartments as would be described by kinetic tracer studies, which are clearly extremely difficult to perform in pregnant women.
In conclusion, increases in maternal plasma DHA concentration occur very early in pregnancy highlighting the importance of DHA at this critical time when neural tube closure takes place.
